LumiThera: LumiThera Receives NIH Grant to Support Dry AMD Trial
LumiThera announced it is a recipient of a small business innovative research (SBIR) phase 2 grant from the National Institute of Health (NIH) of
Read full article »
LumiThera is a Washington-based medical device company that designs and develops photobiomodulation treatment protocols for the treatment of ocular disorders.
Read more